Related Experiment Video
Updated: Jan 15, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Huntington's Disease and Huntington's Disease-like 2 (HDL2) in Martinique
Ignacio Antolin-Sanfeliz1, Anna-Gaelle Giguet-Valard1, Sophie Duclos1
1Centre de Référence Caribéen des Maladies Neuromusculaires Rares, CHU de Martinique, Fort-de-France, France.
Insights
Huntington
Area of Science:
- Neurology
- Genetics
- Rare Diseases
Background:
- Huntington's Disease-like 2 (HDL2) shares clinical similarities with Huntington's Disease (HD) and is primarily observed in individuals with African ancestry.
- The prevalence and clinical characteristics of HDL2 and HD in the Caribbean, specifically Martinique, were previously underexplored.
Purpose of the Study:
- To comprehensively characterize patients with Huntington's Disease (HD) and Huntington's Disease-like 2 (HDL2) in Martinique.
- To compare the clinical features, genetic factors, and disease progression of HD and HDL2 in this population.
Main Methods:
- Retrospective analysis of all HD and HDL2 patients over 20 years at a single neurology center in Martinique.
- Collection of longitudinal clinical data, Unified Huntington's Disease Rating Scale (UHDRS) scores, and CAG repeat lengths.
Main Results:
- The combined minimum prevalence of HD and HDL2 in Martinique was 7.77/100,000.
- HDL2 patients were predominantly male (83%) with motor symptoms as the most frequent initial manifestation, similar to HD.
- Both diseases exhibited negative correlation between repeat length and age of onset, progressive worsening of motor and functional scores in HDL2 mirroring HD, and significant inter- and intra-familial heterogeneity.
Conclusions:
- HDL2 is nearly as prevalent as HD in Martinique, indicating its significant presence in the region.
- The study confirms strong genotype-phenotype correlations and similar disease courses between HD and HDL2, while emphasizing HDL2's heterogeneity and germline instability.
- The findings are limited by the small number of HDL2 families, necessitating cautious interpretation.
Background:
Huntington's Disease-like 2 (HDL2), caused by a CAG repeat expansion in JPH3, closely resembles HD. All reported HDL2 patients to date have some African ancestry. While both disorders exist in the Caribbean, their relative frequency and clinical characteristics remain largely unknown.
Objectives:
To characterize HD and HDL2 patients in Martinique.
Methods:
We retrospectively analyzed all HD and HDL2 patients evaluated over 20 years at a single neurology center in Martinique, collecting longitudinal clinical features, UHDRS scores, and repeat lengths.
Results:
In Martinique, combined HD and HDL2 minimum prevalence was 7.77/100,000. We ascertained 24 HD individuals, from 16 pedigrees, and 18 HDL2 individuals, from two pedigrees, one being the most extensive HDL2 pedigree yet reported. Because most HDL2 patients belong to a single large pedigree, the data must be interpreted with caution as familial clustering may introduce bias. HDL2 cases were predominantly male (83% vs. 45% in HD). Motor symptoms were the most frequent initial manifestation in both. Repeat length negatively correlated with estimated onset age in both diseases. Longitudinal motor (UHDRS-TMS) and functional capacity (UHDRS-TFC) scores in HDL2 revealed progressive worsening similar to HD. Inter- and intra-familial clinical and genetic heterogeneity was obvious in both diseases. Anticipation was not exclusively reserved to paternal transmissions in HDL2.
Conclusions:
HDL2 is nearly as prevalent as HD in Martinique. The study reinforces the similarities between HD and HDL2 in genotype-phenotype correlation and disease course, while highlighting heterogeneity and germline instability in HDL2. Interpretation is limited by the small number of HDL2 families.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Sex-linked Disorders
Parkinson's Disease: Overview
Genetic Lingo
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

